Crossmark

Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results

Crossref DOI link: https://doi.org/10.1186/s13287-018-0784-6

Published Online: 2018-02-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Jianming

Guo, Lianrui

Cui, Shijun

Tong, Zhu

Dardik, Alan

Gu, Yongquan https://orcid.org/0000-0002-2869-9736
Funding

Funding for this research was provided by:

Beijing outstanding talents project (2016000020124G108)

Beijing municipal administration of hospitals clinical technology innovation program (XMLX201610)

Beijing municipal administration of hospitals climbing talent training program (DFL20150801)

Beijing healthcare system specialist training program (2014-3-059)
More Information

Article History

Received: 15 November 2017

Revised: 18 January 2018

Accepted: 19 January 2018

First Online: 22 February 2018

Ethics approval and consent to participate

: Ethics approval for the study was obtained from the Xuanwu Hospital review board and all patients provided written informed consent to participate in the study.

: All related patients and all authors agreed and signed the consent form.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below